BioCentury
ARTICLE | Clinical News

IV APX001: Phase I started

September 19, 2016 7:00 AM UTC

Amplyx began a double-blind, placebo-controlled, dose-escalation, European Phase I trial to evaluate single and multiple doses of IV APX001 in about 80 healthy volunteers. The company plans to begin P...